Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bonny L Bukaveckas

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Annals of Pharmacotherapy|August 7, 2008
Genetic testing for warfarin therapy initiationLauren M Hynicka, William D Cahoon, Bonny L Bukaveckas
Neurotoxicology|February 5, 2003
Manganese distribution across the blood-brain barrier. II. Manganese efflux from the brain does not appear to be carrier mediatedRobert A Yokel, Janelle S Crossgrove, Bonny L Bukaveckas
The Journal of Emergency Medicine|November 3, 2007
The effect of single-dose tramadol on oxycodone clearanceSteven C Curry, David J Watts, Kenneth D Katz, et al.
Neurotoxicology|February 5, 2003
Manganese distribution across the blood-brain barrier. I. Evidence for carrier-mediated influx of managanese citrate as well as manganese and manganese transferrinJanelle S Crossgrove, David D Allen, Bonny L Bukaveckas, et al.
The Journal of Molecular Diagnostics : JMD|April 29, 2008
A simple and rapid genotyping assay for simultaneous detection of two ADRB2 allelic variants using fluorescence resonance energy transfer probes and melting curve analysisM Fernanda Sábato, Anne-Marie Irani, Bonny L Bukaveckas, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|February 13, 2009
A pilot study of genetic polymorphisms and hemodialysis vascular access thrombosisDonald F Brophy, Bonny L Bukaveckas, Andrea Ferreira-Gonzalez, et al.
Journal of Thrombosis and Thrombolysis|August 13, 2003
Warfarin dose adjustments based on CYP2C9 genetic polymorphismsMark W Linder, Stephen Looney, Jesse E Adams, et al.
Thrombosis and Haemostasis|April 21, 2005
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotypeDeepak Voora, Charles Eby, Mark W Linder, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Annals of Pharmacotherapy|August 7, 2008
Genetic testing for warfarin therapy initiationLauren M Hynicka, William D Cahoon, Bonny L Bukaveckas
Neurotoxicology|February 5, 2003
Manganese distribution across the blood-brain barrier. II. Manganese efflux from the brain does not appear to be carrier mediatedRobert A Yokel, Janelle S Crossgrove, Bonny L Bukaveckas
The Journal of Emergency Medicine|November 3, 2007
The effect of single-dose tramadol on oxycodone clearanceSteven C Curry, David J Watts, Kenneth D Katz, et al.
Neurotoxicology|February 5, 2003
Manganese distribution across the blood-brain barrier. I. Evidence for carrier-mediated influx of managanese citrate as well as manganese and manganese transferrinJanelle S Crossgrove, David D Allen, Bonny L Bukaveckas, et al.
The Journal of Molecular Diagnostics : JMD|April 29, 2008
A simple and rapid genotyping assay for simultaneous detection of two ADRB2 allelic variants using fluorescence resonance energy transfer probes and melting curve analysisM Fernanda Sábato, Anne-Marie Irani, Bonny L Bukaveckas, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|February 13, 2009
A pilot study of genetic polymorphisms and hemodialysis vascular access thrombosisDonald F Brophy, Bonny L Bukaveckas, Andrea Ferreira-Gonzalez, et al.
Journal of Thrombosis and Thrombolysis|August 13, 2003
Warfarin dose adjustments based on CYP2C9 genetic polymorphismsMark W Linder, Stephen Looney, Jesse E Adams, et al.
Thrombosis and Haemostasis|April 21, 2005
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotypeDeepak Voora, Charles Eby, Mark W Linder, et al.
Pageof 1